Sorbact Technology

Sorbact® Technology effectively prevents and treats wound infection across all ages, from sensitive children to elderly. Developed with a physical mode of action, bacteria irreversibly bind to the DACC™-coated surface and are safely removed. Evidence presents an antibacterial effect without the release of active substances, and therefore antimicrobial resistance is not expected. Sorbact® Technology dressings deliver powerful, safe and effective wound infection management for the advancement of patient well-being. Sorbact® - Reduces the bioburden in wounds - Safe and easy to use - Helps reduce pain during wear - Helps reduce odor from the wound - No limitation in treatment time - Effective against multi-resistant bacteria Sorbact® Technology dressings are helping patients in more than 65 countries through our brands Sorbact®, Cutimed® Sorbact®, Cutimed® Siltec® Sorbact®, Cutimed® Sorbion® Sorbact® and Leukoplast® Leukomed® Sorbact®. This is a global LinkedIn account. Statements and assortment vary between markets. Outside EU, variations of statements can exist. Find your local Essity representative at For questions, please contact us at info@sorbact.com Sorbact® is a registered trademark of Abigo Medical AB. To learn more visit sorbact.com